Several national health advocacy groups have put out an alert about some key changes to language access standards that have just been proposed for the communication responsibilities of certain federal agencies which regulate private health care plans. As we move forward towards the enactment of health care reform, it is critical that everyone, including LEP [...]
Archive for the ‘Economics of Health Care’ Category
ACTION ALERT: Comments Needed on Important Language Access Standard by July 25
Posted in Advocacy, Consumer Protection, Discrimination, Economics of Health Care, Health Care Marketing, Health Care Reform, Health Insurance, Health Literacy, Language Access, Language Services on 20 July 2011 | Leave a Comment »
Headline Scan
Posted in Access to Medicines, Advocacy, Assistance, Children's Health, Economics of Health Care, Environmental Health, Ethics, Global Health, Health Care Marketing, Health Disparities, Health Insurance, Health Literacy, Healthcare Inequalities, Language Access, Recession, State of Washington, Workers' rights on 18 May 2011 | Leave a Comment »
Can We Afford Personalized Medicine? Special treatment for ‘high profile’ patients; exasperation for the rest of us Health Insurers Making Record Profits as Many Postpone Care People Who Donate Organs For Transplants Can Have Difficulty Getting Insurance Foundations, Conflicts Of Interest And Drugmakers Mission Crash: The Intolerable Policy Incoherence in US AIDS Policy, Global and [...]
Losing Your Job When You Get Sick
Posted in Advocacy, Discrimination, Economics of Health Care, Ethics, Workers' rights on 14 April 2011 | Leave a Comment »
On tonight’s evening news, King 5 TV, our local CBS affiliated carried a story about a Microsoft worker who lost his job after being diagnosed with leukemia. Duncan Sutherland came forward after after seeing another report the night before about Ken Knightley, a Microsoft worker who is now being denied paid leave to undergo treatment [...]
Another drug price story that defies logic
Posted in Access to Medicines, Consumer Protection, Economics of Health Care, Ethics, Health Care Marketing, Health Insurance on 15 December 2010 | Leave a Comment »
A friend recently shared this personal story with me, in the hopes that it will inspire people to demand price controls on drugs, as well as an end to the Rx profiteering by insurance companies. This is a story about a commonly-prescribed generic drug, levothyroxine, used for hypothyroidism and other thyroid conditions. The fact that [...]
